RUNX1 and chronic neutrophilic leukemia: A recent case report by Nooruddin et al. showed that acquiring GATA2 mutations and increased variable allele frequency (VAF) of RUNX1 mutation might play a role in the pathological development of CNL and ruxolitinib resistance [63].